Company: BLND
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001855747-25-000069
Chunk: 361

Company: Blend Labs, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 361
---
$1,376,752 $565 $(1,394,205)$(16,886)Issuance of common stock upon exercise of stock options— — — 222 — 430 — — 430 Vesting of restricted stock units— — — 2,044 — — — — — Shares withheld related to net share settlement of equity awards— — — (695)— (2,531)— — (2,531)Stock-based compensation— — — — — 8,536 — — 8,536 Unrealized loss on investments in marketable securities— — — — — — (44)— (44)Foreign currency translation loss— — — — — — (7)— (7)Accretion of Series A redeemable convertible preferred stock to redemption value— — 4,376 — — (4,376)— — (4,376)Share repurchases— — — (345)— (1,042)— — (1,042)Net loss— — — — — — — (6,645)(6,645)Balances as of June 30, 2025    $— 150 $150,241 260,051 $2 $1,377,769 $514 $(1,400,850)$(22,565)

See accompanying notes to condensed consolidated financial statements 

3

Blend Labs, Inc.

Condensed Consolidated Statements of Redeemable Noncontrolling Interest, Series A Redeemable Convertible Preferred Stock and Stockholders’ Equity (Continued)

(In thousands)

(Unaudited)

Three and Six Months Ended June 30, 2024Redeemable noncontrolling interest - held for sale from discontinued operationsSeries A Redeemable Convertible Preferred StockCommon StockAdditionalPaid-InCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountSharesAmountBalances as of December 31, 2023    $46,190 — $— 249,910 $2 $1,321,944 $441 $(1,341,630)$(19,243)Issuance of common stock upon exercise